Home » Event agendas » Agenda 2 – STEM CELL SCIENCE & REGENERATIVE » Day 1 – STEM CELL SCIENCE & REGENERATIVE

STEM CELL SCIENCE AND REGENERATIVE MEDICINES CONGRESS WORLD CONGRESS 2023 EUROPE

“Revolutionizing the way human diseases are treated”

Day 1 - Thursday 9th March 2023

  • Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies
  • How different markets approach the regulation and commercialization of advanced therapies
  • Current data on how product effects clinical outcomes

PRODUCT, PROCESS AND MANUFACTURING DEVELOPMENT

  • Implications and advances in stem cell therapy (T-Cells, NK Cells, DCs, Vaccines, iPSCs & MSCs)
  • Setting global standards for stem cell research and clinical translation
  • Use of chip-based microsystems for genomic and proteomic analysis
  • Developing nanostructured thin films as biomimetic tissue-engineered platform for cancer research
  • Applications of high-throughput cellular microarray platforms in drug discovery, toxicology and stem cell research
  • Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening
  • Using mouse and human pancreatic organoids to infer resistance to targeted therapy
  • Patient-derived organoids as an in vitro model of neuroendocrine tumors
  • Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure
  • Regulation of ribosome biogenesis and protein synthesis controls germline stem cell differentiation
  • Global regulatory developments for clinical stem cell research
  • Issues surrounding the authentication and quality of induced pluripotent stem cells

STEM CELL PRODUCT, PROCESS AND MANUFACTURING DEVELOPMENT

  • Flow-induced epigenetic mechanisms of endothelial gene expression
  • Emerging role of nutri-epigenetics in inflammation and cancer
  • Epigenomic annotation of regulatory changes in adult tissue and stem cell based models
  • Advancing biomaterials of human origin for tissue engineering
  • Bio-inspired 3D microenvironments for stem cell reprogramming
  • Implementing oxygen control in chip-based cell and tissue culture systems

Process parameters for the high-scale production alginate-encapsulated stem cells for storage and distribution throughout the cell therapy supply chain

CASE STUDY

  • Computational tools for stem cell biology
  • Developing an automated robotic factory for novel stem cell therapy production
  • Issues of supplying new technologies into highly regulated markets

PANEL DISCUSSION 

  • Innovative, comprehensive mapping and multiscale analysis of registered trials for stem cell-based regenerative medicine
  • Failure mode and effects analysis to reduce risks of errors in the good manufacturing practice production of engineered tissue and cells
  • Regulatory requirements in the good manufacturing practice production of an epithelial cell graft for ocular surface reconstruction
Scroll to Top